3.2 Pediatric Pain Assessment Scales & Developmental Screening

Pediatric Pain Assessment Scales & Developmental Screening

Accurate pain assessment and developmental screening are fundamental cornerstones of pediatric nursing practice. Historically, pediatric patients suffered from widespread undertreatment of pain based on erroneous beliefs that immature nervous systems did not perceive noxious stimuli. Contemporary neurobiology proves that nociceptive pathways are fully functional by 24 weeks of gestation, while descending inhibitory pathways remain underdeveloped. Consequently, infants and young children experience heightened pain sensitivity and long-term neurodevelopmental consequences if acute pain is left unmanaged.

---

1. Principles of Pediatric Pain Assessment

Pain is subjective and multifaceted. The pediatric nurse must adhere to a standardized clinical hierarchy when assessing pain:

1. Self-Report: Always the clinical gold standard whenever a child has the cognitive and communicative ability to report pain severity.
2. Behavioral Observations: Utilized when the child cannot self-report due to age, sedation, critical illness, or cognitive impairment. Behaviors include facial grimacing, motor restlessness, crying, guarding, and inability to be consoled.
3. Physiological Indicators: Tachycardia, tachypnea, hypertension, pupillary dilation, diaphoresis, and oxygen desaturation. Caution: Physiological markers habituate rapidly during sustained pain, reflect generalized stress or hypoxia, and must never be used alone to dismiss the presence of pain.

---

2. Neonatal & Pre-Verbal Infant Pain Scales

Neonates and young infants require specialized, validated observational tools tailored to their neurodevelopmental stage.

NPASS (Neonatal Pain, Agitation, and Sedation Scale)

• Target Population: Preterm and full-term neonates in neonatal intensive care units (NICUs) and infant wards up to 100 days of age.
• Unique Clinical Feature: It assesses both acute pain/agitation (positive scores: 0 to +2 per item, total score 0 to 10) AND depth of sedation (negative scores: 0 to -2 per item, total score 0 to -10). This dual assessment makes it ideal for evaluating mechanically ventilated infants receiving continuous opioid or sedative infusions.
• Five Scored Domains:
  1. Crying / Irritability
  2. Behavioral State
  3. Facial Expression
  4. Extremities / Muscle Tone
  5. Vital Signs (Heart Rate, Respiratory Rate, Blood Pressure, SaO2)
• Prematurity Weighting: Infants born at < 28 weeks gestation receive +2 additional points, and those at 28 to 31 weeks receive +1 additional point to compensate for diminished behavioral reserve.

CRIES Scale

• Target Population: Full-term and preterm infants born at 32 weeks gestation or older, particularly validated for postoperative surgical pain.
• Scoring Structure: 5 categories scored 0, 1, or 2 (Total score: 0 to 10):
  • C - Crying: 0 = No cry; 1 = High-pitched cry, consolable; 2 = High-pitched cry, inconsolable.
  • R - Requires O2 for SaO2 > 95%: 0 = Room air; 1 = < 30% FiO2 required; 2 = > 30% FiO2 required.
  • I - Increased Vital Signs: 0 = Heart rate and blood pressure equal to or below baseline; 1 = HR or BP elevated < 20% over baseline; 2 = HR or BP elevated > 20% over baseline.
  • E - Expression (Facial): 0 = Relaxed; 1 = Grimace present; 2 = Grimace with non-cry grunt.
  • S - Sleeplessness: 0 = Sleeps continuously; 1 = Awakens at frequent intervals; 2 = Constantly awake.
• Clinical Action Threshold: A score > 4 indicates significant pain requiring analgesia.

PIPP (Premature Infant Pain Profile)

• Incorporates gestational age, baseline behavioral state, heart rate, oxygen saturation, and three specific facial actions: brow bulge, eye squeeze, and nasolabial furrow.

---

3. The FLACC Behavioral Pain Scale

The FLACC Scale (Face, Legs, Activity, Cry, Consolability) is the most widely utilized and validated observational pain instrument in pediatric nursing. It is indicated for infants and children aged 2 months to 7 years, non-verbal pediatric patients, cognitively impaired children, and patients emerging from general anesthesia in the post-anesthesia care unit (PACU).

Clinical Interpretation and Actions

• Score 0: Relaxed and comfortable (no pain intervention required).
• Score 1 to 3: Mild discomfort (initiate comfort measures, repositioning, non-pharmacologic modalities; consider non-opioid analgesics like acetaminophen or ibuprofen).
• Score 4 to 6: Moderate pain (administer prescribed systemic analgesia, reassess within 30 to 60 minutes).
• Score 7 to 10: Severe discomfort or pain (prompt multimodal analgesia, parenteral opioids as ordered, rapid reassessment).

The Revised FLACC (r-FLACC)

For children with severe cognitive or physical impairments (e.g., severe cerebral palsy), the standard FLACC is modified into the r-FLACC. In the r-FLACC, the nurse collaborates directly with the primary family caregiver to document individualized, baseline behavioral indicators of pain (such as idiosyncratic vocalizations, specific head-banging movements, or unique facial grimaces).

---

4. Self-Report Pain Scales for Verbal Children

Self-report should be implemented as early as developmental cognition permits. The nurse must select the tool that matches the child's numerical and abstract cognitive abilities.

---

5. Developmental Surveillance & Standardized Screening

Developmental Surveillance vs. Formal Screening

• Developmental Surveillance: A flexible, continuous, longitudinal process conducted at every single preventive well-child visit. It includes eliciting parental concerns, obtaining an updated developmental history, observing parent-child interactions, and identifying risk factors.
• Standardized Developmental Screening: The formal administration of an established, validated, norm-referenced screening tool. The American Academy of Pediatrics (AAP) recommends universal standardized developmental screening at:
  • 9 months of age
  • 18 months of age
  • 30 months of age (or at 24 months if a 30-month visit is unavailable)

Common Standardized Developmental Tools

• Ages & Stages Questionnaires, Third Edition (ASQ-3): A parent-completed developmental screening system covering ages 1 month to 5.5 years (66 months). It evaluates five distinct domains:
  1. Communication: Vocalizations, language comprehension, and verbal expression.
  2. Gross Motor: Arm, leg, and postural body movements.
  3. Fine Motor: Hand and finger grasp, eye-hand coordination.
  4. Problem Solving: Learning, manipulation of objects, and cognitive problem-solving.
  5. Personal-Social: Solitary and interactive social play, self-help skills (feeding, dressing).
  • Scoring: Total domain scores falling below established empirical cutoff lines indicate suspected developmental delay, requiring immediate referral to state-sponsored Part C Early Intervention services.
• Denver Developmental Screening Test II (Denver II): An examiner-administered tool evaluating 125 functional items across four streams: Personal-Social, Fine Motor-Adaptive, Language, and Gross Motor from birth through 6 years of age. Identifies developmental "cautions" and "delays."

---

6. Universal Autism Spectrum Disorder (ASD) Screening: M-CHAT-R/F

The AAP mandates universal screening for Autism Spectrum Disorder (ASD) at 18 months and 24 months of age, or at any time a parent or clinician raises concerns regarding social communication.

Architecture of the M-CHAT-R/F

The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) is a 20-item, parent-completed screening tool focusing on joint attention, social reciprocity, and communication behaviors (e.g., pointing to show interest, eye contact, responding to name, bringing objects to show parents).

Scoring Algorithm & Clinical Risk Tiers

• Low Risk (Total Score: 0 to 2):
  • Action: If the child is younger than 24 months, rescreen at the 24-month well visit. No further diagnostic action needed unless clinical surveillance reveals red flags.
• Medium Risk (Total Score: 3 to 7):
  • Action: Administer the structured M-CHAT-R/F Follow-Up Interview (in person or via telephone) for each failed item.
  • If the follow-up score remains ≥ 2, the screen is considered positive: immediately refer the child for comprehensive diagnostic evaluation and early intervention.
  • If the follow-up score is 0 to 1, the screen is considered passed; rescreen at subsequent visits as indicated.
• High Risk (Total Score: 8 to 20):
  • Action: Bypass the follow-up interview! The child has screened strongly positive. Immediately refer for a comprehensive multidisciplinary autism evaluation and simultaneously enroll in state Part C Early Intervention services. Never delay referral to "wait and see"!

---

7. Pediatric Sensory Screening: Vision & Hearing

Vision Screening Guidelines

• Newborn to 3 Years:
  • Red Reflex Test (Bruckner Test): Inspect both eyes simultaneously using a direct ophthalmoscope set at 0 diopters from a distance of 18 to 24 inches in a darkened room. Normal red reflex is bright, symmetric, and reddish-orange. Absence of red reflex or presence of an abnormal white reflex (leukocoria) is an absolute medical emergency, indicating retinoblastoma, congenital cataracts, or persistent fetal vasculature.
  • Fixation & Following: Term infants fixate on faces by 4 to 6 weeks and track objects smoothly across 180 degrees by 3 to 4 months.
  • Strabismus Evaluation: Utilize the corneal light reflex (Hirschberg test) and the cover-uncover test. Intermittent strabismus is common in early infancy, but persistent or new-onset strabismus after 4 to 6 months is abnormal and requires pediatric ophthalmology referral to prevent irreversible cortical amblyopia (lazy eye).
• Visual Acuity Testing (Ages 3 Years and Older):
  • Ages 3 to 5: Use standardized optotypes including LEA Symbols (circle, square, apple, house) or HOTV matching charts.
  • Ages 6 and older: Utilize the standard Snellen letter chart.
  • Referral Criteria for Ophthalmology:
    • Age 3 to 4 years: Visual acuity worse than 20/40 in either eye.
    • Age 5 years: Visual acuity worse than 20/30 in either eye.
    • Any Age: A difference of two or more lines between eyes (e.g., 20/25 in one eye and 20/40 in the other), even if the weaker eye passes the minimum threshold.

Hearing Screening Guidelines & The JCIH 1-3-6 Benchmark

• Universal Newborn Hearing Screening (UNHS): Performed before nursery discharge using Otoacoustic Emissions (OAE) or Automated Auditory Brainstem Response (AABR).
• The Joint Committee on Infant Hearing (JCIH) 1-3-6 Rule:
  • "1" (By 1 Month): Universal hearing screening completed for all infants prior to hospital discharge or before 1 month of life.
  • "3" (By 3 Months): Comprehensive diagnostic audiological evaluation completed for all infants who fail the initial screen.
  • "6" (By 6 Months): Comprehensive family-centered early intervention services initiated for all infants with confirmed sensorineural or conductive hearing loss to safeguard speech and language development.
• Pure-Tone Audiometric Screening: Performed annually at preventive well visits at ages 4, 5, 6, 8, and 10 years, and once during middle school and high school. The child is tested at 1000, 2000, and 4000 Hz at a 20 dB HL threshold.